InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Zhai Yifan. Director active across 1 company, notably ASCENTAGE PHARMA GROUP INTERNATIONAL. In total, 2 disclosures have been published. Activity tracked since 21 May 2026. The latest transaction was filed on 21 May 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations